Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.560
-0.090 (-5.45%)
At close: Nov 20, 2024, 4:00 PM
1.600
+0.040 (2.56%)
Pre-market: Nov 21, 2024, 7:00 AM EST

Cardiol Therapeutics Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Revenue
---0.08--
Upgrade
Gross Profit
---0.08--
Upgrade
Selling, General & Admin
24.4915.5622.3727.8710.094.95
Upgrade
Research & Development
13.8214.2218.9610.8710.63.53
Upgrade
Operating Expenses
38.3229.7941.3438.7420.6911.89
Upgrade
Operating Income
-38.32-29.79-41.34-38.66-20.69-11.89
Upgrade
Interest Expense
------0
Upgrade
Interest & Investment Income
1.332.041.240.110.080.25
Upgrade
Currency Exchange Gain (Loss)
0.01-0.712.761.89-0.03-0.1
Upgrade
Other Non Operating Income (Expenses)
0.830.336.415.030.01-1.94
Upgrade
Pretax Income
-36.14-28.13-30.93-31.64-20.64-13.68
Upgrade
Net Income
-36.14-28.13-30.93-31.64-20.64-13.68
Upgrade
Net Income to Common
-36.14-28.13-30.93-31.64-20.64-13.68
Upgrade
Shares Outstanding (Basic)
686463433026
Upgrade
Shares Outstanding (Diluted)
686463433026
Upgrade
Shares Change (YoY)
5.66%3.13%44.61%44.77%15.63%67.97%
Upgrade
EPS (Basic)
-0.53-0.44-0.49-0.73-0.69-0.53
Upgrade
EPS (Diluted)
-0.53-0.44-0.49-0.73-0.69-0.53
Upgrade
Free Cash Flow
-25.96-25.24-27.3-23.55-9.17-11.8
Upgrade
Free Cash Flow Per Share
-0.38-0.39-0.44-0.54-0.31-0.46
Upgrade
Gross Margin
---100.00%--
Upgrade
Operating Margin
----49091.93%--
Upgrade
Profit Margin
----40170.45%--
Upgrade
Free Cash Flow Margin
----29904.22%--
Upgrade
EBITDA
-37.98-29.59-41.16-38.44-20.46-11.77
Upgrade
D&A For EBITDA
0.340.20.180.220.230.13
Upgrade
EBIT
-38.32-29.79-41.34-38.66-20.69-11.89
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.